Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The efficiency concept in pharmacodynamics.

G Alván1, G Paintaud, M Wakelkamp

  • 1Karolinska Institutet, Huddinge University Hospital, Sweden. gunnar.alvan@labtek.ki.se

Clinical Pharmacokinetics
|June 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancer.

European journal of clinical pharmacology·2021
Same author

Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.

The Journal of antimicrobial chemotherapy·2016
Same author

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Clinical and experimental immunology·2015
Same author

Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis.

The British journal of dermatology·2015
Same author

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.

Journal of controlled release : official journal of the Controlled Release Society·2014
Same author

[N-methyl-D-aspartate receptor antibody encephalitis: value of immunomodulatory therapy].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014

This review introduces drug efficiency, measuring effect per concentration, as an alternative to traditional models. Optimizing drug administration schedules can maximize therapeutic benefits and minimize adverse effects.

Area of Science:

  • Pharmacology
  • Pharmacokinetics
  • Pharmacodynamics

Background:

  • Traditional drug response analysis relies on concentration-effect relationships using models like maximum effect (Emax).
  • An alternative metric, drug efficiency, quantifies effect per unit of drug concentration.
  • This concept is analogous to efficiency measures in other scientific fields.

Purpose of the Study:

  • To discuss drug efficiency as an alternative to simple effect measurements.
  • To explore the pharmacodynamic model for efficiency derived from the sigmoid Emax model.
  • To examine the applicability and implications of drug efficiency in various therapeutic contexts.

Main Methods:

  • Derivation of the pharmacodynamic model for efficiency from the sigmoid Emax model.

Related Experiment Videos

  • Analysis of efficiency's dependence on parameters like slope factor (s) and C50.
  • Review of existing literature and examples of efficiency application in different drug classes.

    • Main Results:

    • Drug efficiency decreases with increasing concentration due to diminishing returns.
    • Efficiency has a maximum value, calculable under specific conditions (slope factor > 1).
    • Slow administration of furosemide demonstrated increased diuretic effect per drug amount.

    Conclusions:

    • Drug efficiency is a valuable concept applicable to Emax and sigmoid Emax model drugs.
    • Factors like saturable processes, tolerance, and counter-regulation influence drug efficiency and schedule dependency.
    • Optimizing drug administration profiles can enhance therapeutic outcomes and reduce adverse effects, impacting drug development and scheduling.